Illinois Tool Works Inc. vs Revvity Inc — how do they compare? Illinois Tool Works Inc. trades at $263.78 (market cap $74.38B), while Revvity Inc trades at $154.1 (market cap $16.98B). The key difference: Illinois Tool Works Inc. is far larger — about 4.4× Revvity Inc's market cap, and Illinois Tool Works Inc. pays the higher dividend (2.63%). Which is the better fit depends on your goals — on Pluang, investors hold Illinois Tool Works Inc. for 67 Days and Revvity Inc for 12 Days on average.
| ITW | RVTY | |
|---|---|---|
Market Cap | $74.38B | $16.98B |
Volume | 1,125,477 | 1,456,900 |
Sector | Industrials | Health |
52-Week High | $299.60 | $157.36 |
52-Week Low | $241.07 | $82.26 |
Typical Hold Time | 67 Days | 12 Days |
Enterprise Value | $83.23B | $19.30B |
Dividend Yield | 2.63% | 0.18% |
Signals from Pluang's Aura AI — not financial advice
ITW trades at $264.42, up 1.25% with consistent earnings beats in recent quarters. The stock shows bearish technical signals but maintains strong fundamentals with 19.39% net margins and 104.65% ROE. Recent dividend increase to $1.72 reinforces its 59-year dividend growth streak. Revenue stability around $16B and operational cash flow exceeding $3B demonstrate business resilience despite mixed analyst sentiment.
Outlook remains balanced with upside to $276.86 consensus target but technical weakness near-term. Key opportunities include dividend reliability and margin strength, while risks involve debt levels at 55.54% of assets and sector cyclicality. The stock offers quality exposure for dividend-growth investors despite current technical headwinds.
RVTY trades at $155.01, up 0.92% with a bullish technical outlook. The stock shows strong earnings momentum with three consecutive quarterly beats and maintains solid profitability with 54.98% gross margins. Recent developments include new product launches in Europe and strategic acquisitions to expand metabolic disease research capabilities.
The investment case balances premium valuation (P/E 73.15) against consistent execution and growth initiatives. Key risks include China market pressures and margin compression, while analyst consensus remains positive with 52% buy ratings. Upside potential exists if Q3 earnings meet expectations in November.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →